IRVINE, Calif., Jan. 27, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2020. Fourth Quarter Highlights and Outlook Q4 sales increased 1 percent to $1.2 billion; underlying1 sales flat Q4 TAVR sales grew 2 percent; underlying sales flat Q4 EPS was $0.49; adjusted1 EPS grew 2 percent to $0.50 […]
